Quality of health care, accreditation, and health technology assessment in Croatia: Role of agency for quality and accreditation in health;Kvaliteta Zdravstvene Zaštite, Akreditacija Nositelja Zdravstvene Djelatnosti I Procjena Zdravstvenih Tehnologija u Hrvatskoj: Uloga Agencije za Kvalitetu i Akreditaciju u Zdravstvu

Acta Medica Croatica

Volumn 64, Issue 5, 2010, Pages 425-434

  Mittermayer, R ^a   Huic M ^a   Mestrovic J ^a  

^a Agency for Quality and Accreditation in Health   (Croatia)

Author keywords

Accreditation; Agency for Quality and Accreditation in Health; Croatia; Health care quality; Health technology assessment

Indexed keywords

ACCREDITATION; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CROATIA; GOVERNMENT; HEALTH CARE QUALITY; HUMAN;

ACCREDITATION; CROATIA; GOVERNMENT AGENCIES; HUMANS; QUALITY OF HEALTH CARE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 79960092864     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Official Journal of the European Commities. Charter of fundamental rights of the European Union (2000/C 364/01). Dostupno na URL adresi: http://www.europarl. europa.eu/charter/pdf/text-en.pdf. Datum pristupa informaciji 25. listopada 2010.
2. Nacionalna strategija razvitka zdravstva 2006.- 2011. Dostupno na URL adresi: http://www.nhs.hr/download/Nacionalna-strategija-razvitka-zdravstva- 2006-2011.pdf. Datum pristupa informaciji 25. listopada 2010.
3. Bewick DM. Continuous improvement as an ideal in health care. N Engl J Med 1989; 320: 53-56.
4. Batalden PB, Davidoff F. What is "quality improvement" and how can it transform healthcare? Qual Saf Health Care 2007; 16: 2-3. (Pubitemid 46347941)
5. Eldar R. Vrsnoća medicinske skrbi. Medicinska naklada, Zagreb, 2003.
6. Ogrinc GS, Headrich LA. Fundamentals of Health Care Improvement: a Guide to improving your patients care. Joint Commission, Illinois, USA, 2008.
7. Jha AK, Prasopa Plaizier N, Larizgoitia I i sur. Patient safety research: an overview of the global evidence. Qual Saf Health Care 2010; 19: 42-47.
8. Leape L, Berwick D, Clancy C i sur. Transforming healthcare: a safety imperative. Qual Saf Health Care 2009; 18: 424-428.
9. de Vos M, Graafmans W, Kooistra M i sur. Using quality indicators to improve hospital care: a review of the literature. Int J Qual Health Care 2009; 21: 119-29.
10. Zakon o kvaliteti zdravstvene zaštite. Dostupno na URL adresi: http://narodne-novine.nn.hr/clanci/sluzbeni/2007-10-107-3129.html. Datum pristupa informaciji 22. listopada 2010.
11. Shaw C, Kutryba B, Braithwaite J, Bedelicki M, Warunek A. Sustainable healthcare accreditation: messages from Europe in 2009. Int J Qual Health Care 2010; 22: 341-50.
12. Agencija za kvalitet i akreditaciju u zdravstvu FbiH (Sarajevo). Akreditacijski standardi za bolnice. Sarajevo: Avicena, 2005.
13. Podrška Agenciji za akreditaciju zdravstvenih ustanova Srbije. Dostupno na URL stranici: http://www. accreditationproject.rs/. Datum pristupa informaciji: 27. listopada 2010.
14. Robida A. Manual for Internal Assessment - Self- Assessment of Hospitals. Ljubljana: Ministry of Health, 2004.
15. Battista RN, Hodge NJ. The development of health care technology assessment. An international perspective. Int J Technoly Assess Health Care 1995;11: 287-300.
16. Garrido MV, Kristensen FB, Nielsen CP, Busse R. Health Technology Assessment and health policy-making in Europe. Current status, challenges and potential. Observatory Studies Series No14, World Health Organization 2008, on behalf of the European Observatory on Health Systems and Policies.
17. Council Directive 89/105/EEC of 21 December 1998 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance system; Official J L 040, 11/02/1989, P. 0008 - 0011. Dostupno na URL adresi: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31989L0105: EN:HTL. Datum pristupa informaciji 28. listopada 2010.
18. Council of the European Union. Position of the Council at first reading with a view to the adoption of a Directive of the European Parliament and of the Council on the application of patients' rights in cross-border healthcare. Chapter IV, Cooperation in healthcare, Article 14, Cooperation on health technology assessment, Brussels, 13 September 2010. Dostupno na URL adresi: http://register. consilium.europa.eu/pdf/en/10/st11/st11038-re02.en10. pdf. Datum pristupa informaciji 28. listopada 2010.
19. WHO. The Tallin Charter: health system for health and wealth. 2008. Dostupno na URL adresi:http://www. euro.who.int/-data/assets/pdf-file/0008/ 88613/E9 1438.pdf. Datum pristupa informaciji 27. listopada 2010.
20. Neumann PJ, Fang CH, Cohen JT. 30 years of pharmaceutical cost-utility analyses, grow, diversity and methodological improvement. Pharmacoeconomics 2009; 27: 861-72.
21. Sermet C, Andrieu V, Godman B, Van Ganse E, Haycox A, Reynier JP. Ongoing pharmaceutical reforms in France. Implications for key stakeholder groups. Appl Health Econ Health Policy 2010; 8: 7-24.
22. Garattini L, Koleva D, Casadei G. Modeling in pharmacoeconomic studies: funding sources and outcomes. Int J Technol Assess Health Care 2010; 26: 330-33.
23. Fronsdal KB, Facey K, Klemp M, Norderhaug IN, Morland B, Rottingen JA. On behalf of the HTAi Policy Forum. HTA to optimize health technology utilization: using implementation initiatives and monitoring processes. Int J Technol Assess Health Care 2010; 26: 309-16.
24. Bell CM, Urbach DR, Ray JG i sur. Bias in published cost effectivenes studies: systematic review. BMJ 2006; 332 : 699 doi:10.1136/bmj.38737.607558.80. (Pubitemid 44365687)
25. Jorgensen AW, Hilden J, Gotzsche PC. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006; 333: 782.
26. International Network of Agencies for Health Technology Assessment. About HTA. Dostupno na URL adresi: http://www.inahta.org/HTA. Datum pristupa informaciji 27. listopada 2010.
27. Kristensen FB, Sigmund H (ed.) Health Technology Assessment Handbook. Copenhagen: Danish Centre for Health Technology Assessment, National Board of Health, 2007. Dostupno na URL adresi: http://www.sst. dk/publ/Publ2008/MTV/ Metode/HTA-Handbook- net-final.pdf. Datum pristupa informaciji 27. listopada 2010.
28. Drummond MF, Schwartz JS, Jonsson B i sur. Key principles for the imroved conduct of health technology assessment for resource allocation decisions. Int J Technol Assess Health Care 2008; 24: 244-58. (Pubitemid 351950160)
29. NHS National Institute for Health and Clinical Excellence. Guide to the single technology appraisal process, 2009.
30. NHS National Institute for Health and Clinical Excellence. Guide to the multiple technology appraisal process, 2009.
31. EUnetHTA documents: HTA Core Model for Medical and Surgical Interventions, and HTA Core Model for Diagnostic Technologies. Dostupno na URL adresi: https://fio.stakes.fi/htacore/handbook.html. Datum pristupa informaciji 28. listopada 2010.
32. Mesarić J. Nacionalna konferencija "PATH '09 u Hrvatskoj". 2009; [2 stranice] Dostupno na URL adresi: http://www. zdravstvo-kvaliteta.org/. Datum pristupa informaciji 26. listopada 2010.
33. Ministarstvo zdravstva i socijalne skrbi. Projekt: Kategorizacija i akreditacija bolnica u Republici Hrvatskoj - Faza 1, Produkt 3: Kategorizacija i akreditacija: medunarodna iskustva. Zagreb, 2005.
34. NHS National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal, 2008.
35. The Canadian Agency for Drugs and Technologies in Health (CADTH). Guidelines for Authors of CADTH Health Technology Assessment Reports, 2003.
36. Cleemput I, Van Den Bruel A, Kohn L i sur. Search for Evidence & Critical Appraisal: Health Technology Assessment (HTA). Brussels: Belgian Health Care Knowledge Centre (KCE); 2007. KCE process notes (D2007/10.273/40).
37. EUnetHTA Adaptation Toolkit. Dostupno na URL adresi: http://www.eunethta. net/upload/WP5/EUnetHTA- HTA-Adaptation-Toolkit-October08.pdf Datum pristupa informaciji 29. listopada 2010.
38. Higgins JPT, Green S, ur. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Dostupno na URL adresi: www.cochrane-handbook. org. Datum pristupa informaciji 28. listopada 2010.
39. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Dostupno na URL adresi: http://srdta.cochrane.org/handbook-dta-reviews. Datum pristupa informaciji 29. listopada 2010.
40. Khan KS, Ter Riet G, Glanville J, Sowden AJ, Kejnen J, ur. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. 2nd ed. York (UK): NHS Centre for Reviews and Dissemination, University of York; 2001. (CRD report no.4.) Dostupno na URL adresi: http://www.york.ac.uk/inst/crd/report4.htm. Datum pristupa informaciji 29. listopada 2010.
41. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009; 6(7): e1000097.
42. Stroup DF, Berlin JA, Morton SC i sur. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12. (Pubitemid 30214957)
43. INAHTA checklist for the appraisal of HTA reports. Dostupno na URL adresi: http://www.dimdi.de/static/de/hta/methoden/sammlung/inahtachecklist. pdf. Datum pristupa informaciji 28. listopada 2010.
44. Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada. Dostupno na URL adresi: http://www.cadth.ca/media/pdf/186-EconomicGuidelines-e. pdf. Datum pristupa informaciji 29. listopada 2010.
45. Mittmann N, Evans WK, Rocchi A i sur. Addendum to CADTH's Guidelines for the Economic Evaluation of Health Technologies: Specific Guidance for Oncology Products. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2009.
46. Drummond MF, Sculpher MK, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. London: Oxford University Press, 2009.
47. Wells GA, Sultan SA, Chen L, Khan M, Coyle D. Indirect Evidence: Indirect Treatment Comparisons in Meta- Analysis [Internet]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2009. 92 p. [cited 2009Nov 3]. (Technology report). Dostupno na URL adresi: http://www.cadth.ca/index.php/en/hta/ reportspublications/search/publication/884. Datum pristupa informaciji 29. listopada 2010.